Women In Consulting Member Directory

< Back to Member Directory

ZephyrBiotech, LLC

About ZephyrBiotech, LLC:

ZephyrBiotech LLC has radically re-defined Project Management to support the needs of virtual, emergent and early stage life science companies.

Our firm is based on the premise that the business objectives of highly innovative companies are best served by a more sophisticated, imaginative project management style that blends both strategic and tactical elements in an agile, stage-appropriate manner.

We place emphasis on ‘doing the right things with the right people’ to achieve our clients’ product R & D and corporate sustainability goals.

Leveraging our broad and deep domain knowledge in the bio/pharmaceutical industry, ZephyrBiotech is clearly differentiated in its focus on earlier stage companies where value-driving decision making is of top importance for advancing product candidates through the pipeline.

Focus: ZephyrBiotech LLC was formed by highly experienced healthcare executives with international track records in the biopharmaceutical industry. Based in the Bay Area of San Francisco, the center of biopharmaceutical investment, ZephyrBiotech provides solutions to meet the strategic and operational needs of early stage life science companies through its widely acknowledged expertise in Project Management and Strategic Planning.

What We Offer: ZephyrBiotech provides Interim Project Management to Life Science companies in the following areas: – Biotechnology – Pharmaceuticals – Medical Diagnostics – Medical Devices – Technology/Discovery Platforms – Tools/Services

Elise Brownell

Founding Partner

Biotechnology • Global Cross-Functional Team Leadership • Communication • Board of Directors

About Elise Brownell:

I am the founder of ZephyrBiotech, LLC, a company that specializes in fractional cross-functional team leadership for progressive biopharmaceutical companies. With over 30 years of executive-level experience in the life science industry, I have a proven track record of delivering strategic and operational solutions in areas such as therapeutic development planning, matrixed core team management/leadership, stakeholder communications, search and evaluation, due diligence, and operations re-engineering.

My current and past clients include those with small compound and recombinant protein therapies in early development (pre-IND through Phase 2 clinical), and novel blood-based diagnostics. I leverage my extensive background in discovery research, licensing, and program/portfolio leadership gained from global positions at Bayer Healthcare and Aerovance, as well as several consulting engagements in the biopharmaceutical and angel investment sectors. I am passionate about creating operational, strategic, and leadership processes that enable team members to achieve audacious milestones within productive collaborations. I am adept at synthesizing, distilling, and presenting complex information in a memorable and compelling way to diverse audiences, and establishing a culture of learning and continuous improvement. I am also committed to supporting women-based initiatives in the for-profit and nonprofit sectors, and sit on Advisory Boards as well as serving as a Board Director.